New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Haleon plc
HLN
Shape
US Flag

NYSE

45B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

45B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

9.93USD
Shape-0.06 ( -0.55%)
favorite-chart

Relative Strenght

50
favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 29, 2024
1W 0.15 % 1M -6.29 % 3M 9.56 % 1Y 25.82 %

Key Metrics

Shape
  • Market Cap

    45.23B


  • Shares Outstanding

    4.56B


  • Share in Float

    4.56B


  • Dividende

    0.16


  • Earning Date

    07 Nov 2024


  • Price Target

    9.925


  • Average Volume

    5.06M


  • Beta

    0.187


  • Range

    7.695-10.8


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.haleon.com


  • Sector

    Healthcare


Fundamentals

Shape

1.45x

P/E Ratio

3.10x

P/S Ratio

4.23x

P/B Ratio

0.5

Debt/Equity

9.7%

Net Margin

$0.3

EPS

How HLN compares to sector?

P/E Ratio

Relative Strength

Shape

HLN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$12B

Shape316%

2025-Revenue

$0.18

Shape458%

2025-EPS

$2B

Shape350%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

downgrade

Previous: Not converted

2024-08-06

Now: Neutral

HSBC

initialise

Previous: Not converted

2024-04-17

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-7%

0.07
vs 0.08

Q4.22

arrow
arrow

-81%

0.02
vs 0.11

Q1.23

arrow
arrow

+35%

0.1
vs 0.07

Q2.23

arrow
arrow

+84%

0.08
vs 0.04

Q3.23

arrow
arrow

+34%

0.1
vs 0.07

Q4.23

arrow
arrow

+30475%

6.54
vs 0.02

Q1.24

arrow
arrow

+20%

0.12
vs 0.1

Q2.24

arrow
arrow

N/A

0.08
vs 0.08

Q3.24

arrow
arrow

-24%

0.08
vs 0.1

Q4.24

arrow
arrow

-97%

0.18
vs 6.54

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+16%

2.9B  vs 2.5B

Q4.22

arrow
arrow

+159%

3.8B  vs 1.5B

Q1.23

arrow
arrow

+14%

3B  vs 2.6B

Q2.23

arrow
arrow

+7%

2.8B  vs 2.6B

Q3.23

arrow
arrow

-3%

2.8B  vs 2.9B

Q4.23

arrow
arrow

-27%

2.8B  vs 3.8B

Q1.24

arrow
arrow

-2%

2.9B  vs 3B

Q2.24

arrow
arrow

+1%

2.8B  vs 2.8B

Q3.24

arrow
arrow

+14%

3.2B  vs 2.8B

Q4.24

arrow
arrow

+146%

6.8B  vs 2.8B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1%

0.01
vs 0.01

Q4.22

arrow
arrow

+1%

0.01
vs 0.01

Q2.23

arrow
arrow

+2%

0.02
vs 0.01

Q2.23

arrow
arrow

+2%

0.02
vs 0.02

Q3.23

arrow
arrow

+2%

0.02
vs 0.02

Q4.23

arrow
arrow

0%

-0.00
vs 0.02

Q1.24

arrow
arrow

+3%

0.03
vs -0.00

Q2.24

arrow
arrow

+2%

0.02
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

538

538
vs NA

NA

Q4.22

arrow
arrow

590

590
vs 538

10%

Q1.23

arrow
arrow

573

573
vs 590

-3%

Q2.23

arrow
arrow

575

575
vs 573

0%

Q3.23

arrow
arrow

564

564
vs 575

-2%

Q4.23

arrow
arrow

587

587
vs 564

4%

Q1.24

arrow
arrow

596

596
vs 587

2%

Q2.24

arrow
arrow

560

560
vs 596

-6%

Earnings Growth

Latest News